Story · Longevity & Aging
Voyager to showcase two tau therapies at CTAD 2026
1 outlet · first reported by Longevity.Technology 13d ago
Coverage, in order
-
13d agoVoyager to showcase two tau therapies at CTAD 2026
Voyager Therapeutics announced two poster presentations at the 19th Clinical Trials on Alzheimer’s Disease conference in Boston, scheduled for 16-19 November 2026. The posters will highlight VY1706, an investigational gene therapy designed to lower tau production in the brain, and VY7523, a…
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.